← Leaderboards
Jiali Han
Brigham And Women'S Hospital
$3,733,921
Attributed
$3,733,921
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$3,733,921 · 10
By mechanism
R01$2,419,959 · 2
R03$1,313,962 · 8
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Genetic Variant”
- Richard A Gibbs · Baylor College Of Medicine$370,015,672
- Richard K. Wilson · Washington University$221,917,930
- Stacey Gabriel · Massachusetts Institute Of Technology$134,153,706
- David Heimbrook · Leidos Biomedical Research, Inc.$117,485,565
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$86,197,161
- Margaret A Pericak-Vance · Doheny Eye Institute$84,831,559
Research focus
Genetic VariantVariantGenesNurses&AposHealth StudyFollow-UpInnovationCohortPathway InteractionsCharacteristicsProspectiveInheritedDesignSamplingSample SizeVariation (Genetics)ResponseBaseCodeMelanomaPlayGeneticGene Environment InteractionDna Damage
Grant awards (22)
Integrative functional characterization of genetic loci for cutaneous basal cell carcinoma$173,523
R03 · FY2020 · CA · contact PI
Integrating Genetics of Gene Expression into Pathway Analysis for Skin SCC GWAS$83,437
R03 · FY2019 · CA · contact PI
Integrating Genetics of Gene Expression into Pathway Analysis for Skin SCC GWAS$96,831
R03 · FY2018 · CA · contact PI
Genome-Wide Gene-Caffeine Interactions on Risk of Skin Basal Cell Carcinoma2$83,082
R03 · FY2015 · CA · contact PI
Genome-Wide Gene-Caffeine Interactions on Risk of Skin Basal Cell Carcinoma2$88,073
R03 · FY2014 · CA · contact PI
Integrating Genetics of Gene Expression into Pathway Analysis for Melanoma GWAS$78,945
R03 · FY2013 · CA · contact PI
Integrating Genetics of Gene Expression into Pathway Analysis for Melanoma GWAS$12,813
R03 · FY2013 · CA · contact PI
Cohort Study of Genetic Susceptibility to Cutaneous Malignant Melanoma$360,695
R01 · FY2010 · CA · contact PI
Cohort Study of Genetic Susceptibility to Cutaneous Malignant Melanoma$360,731
R01 · FY2009 · CA · contact PI
Cohort Study of Genetic Susceptibility to Cutaneous Malignant Melanoma$346,579
R01 · FY2009 · CA · contact PI
Prospective Study of DNA Repair Gene Variants in Breast Cancer$329,823
R01 · FY2009 · CA · contact PI
Prospective study of telomere length and melanoma risk$87,608
R03 · FY2009 · CA · contact PI
Cohort Study of Genetic Susceptibility to Cutaneous Malignant Melanoma$360,688
R01 · FY2008 · CA · contact PI
Prospective Study of DNA Repair Gene Variants in Breast Cancer$330,435
R01 · FY2008 · CA · contact PI
Prospective study of telomere length and melanoma risk$87,778
R03 · FY2008 · CA · contact PI
Genetic Variants in Pigmentation Genes and Skin Cancer Risk$87,500
R03 · FY2008 · CA · contact PI
Genetic Variants in Immunological Mediator Genes and Skin Cancer Risk$86,936
R03 · FY2008 · CA · contact PI
Prospective Study of DNA Repair Gene Variants in Breast Cancer$331,008
R01 · FY2007 · CA · contact PI
Genetic Variants in Pigmentation Genes and Skin Cancer Risk$87,500
R03 · FY2007 · CA · contact PI
Genetic Variants in Immunological Mediator Genes and Skin Cancer Risk$86,936
R03 · FY2007 · CA · contact PI
Nucleotide Excision Repair Gene Variants and Skin Cancer$86,500
R03 · FY2005 · CA
Nucleotide Excision Repair Gene Variants and Skin Cancer$86,500
R03 · FY2004 · CA